Correlation Between NewAmsterdam Pharma and BiOasis Technologies
Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and BiOasis Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and BiOasis Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NewAmsterdam Pharma and biOasis Technologies, you can compare the effects of market volatilities on NewAmsterdam Pharma and BiOasis Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of BiOasis Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and BiOasis Technologies.
Diversification Opportunities for NewAmsterdam Pharma and BiOasis Technologies
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between NewAmsterdam and BiOasis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and biOasis Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on biOasis Technologies and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with BiOasis Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of biOasis Technologies has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and BiOasis Technologies go up and down completely randomly.
Pair Corralation between NewAmsterdam Pharma and BiOasis Technologies
Given the investment horizon of 90 days NewAmsterdam Pharma is expected to generate 11.62 times less return on investment than BiOasis Technologies. But when comparing it to its historical volatility, NewAmsterdam Pharma is 9.07 times less risky than BiOasis Technologies. It trades about 0.04 of its potential returns per unit of risk. biOasis Technologies is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 0.40 in biOasis Technologies on August 29, 2024 and sell it today you would lose (0.39) from holding biOasis Technologies or give up 97.5% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
NewAmsterdam Pharma vs. biOasis Technologies
Performance |
| Timeline |
| NewAmsterdam Pharma |
| biOasis Technologies |
NewAmsterdam Pharma and BiOasis Technologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NewAmsterdam Pharma and BiOasis Technologies
The main advantage of trading using opposite NewAmsterdam Pharma and BiOasis Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, BiOasis Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BiOasis Technologies will offset losses from the drop in BiOasis Technologies' long position.| NewAmsterdam Pharma vs. Eliem Therapeutics | NewAmsterdam Pharma vs. Scpharmaceuticals | NewAmsterdam Pharma vs. Milestone Pharmaceuticals | NewAmsterdam Pharma vs. Seres Therapeutics |
| BiOasis Technologies vs. Rezolute | BiOasis Technologies vs. Tempest Therapeutics | BiOasis Technologies vs. Forte Biosciences | BiOasis Technologies vs. Dyadic International |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |